The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.
Nature Cell Biology.
Times cited: 57
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.
Journal of Experimental Medicine.
Times cited: 19